{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:29:07Z","timestamp":1791311347012,"version":"4.3.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,6]]},"DOI":"10.7759\/cureus.50017","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T08:28:02Z","timestamp":1701851282000},"source":"Crossref","is-referenced-by-count":17,"title":["Myasthenia Gravis: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Aneesh K","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuj","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semerg.2018.01.003","article-title":"An update on myasthenia gravis [Article in Spanish]","volume":"44","author":"Mart\u00ednez Torre S","year":"2018","unstructured":"Mart\u00ednez Torre S, G\u00f3mez Molinero I, Mart\u00ednez Gir\u00f3n R. An update on myasthenia gravis [Article in Spanish]. Semergen. 2018, 44:351-4. 10.1016\/j.semerg.2018.01.003","journal-title":"Semergen"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis: classification, clinical Presentation, natural History, and epidemiology","volume":"36","author":"Hehir MK","year":"2018","unstructured":"Hehir MK, Silvestri NJ. Generalized myasthenia gravis: classification, clinical Presentation, natural History, and epidemiology. Neurol Clin. 2018, 36:253-60. 10.1016\/j.ncl.2018.01.002","journal-title":"Neurol Clin"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1203679","article-title":"The growing burden of generalized myasthenia gravis: a population-based retrospective cohort study in Taiwan","volume":"14","author":"Herr KJ","year":"2023","unstructured":"Herr KJ, Shen SP, Liu Y, Yang CC, Tang CH. The growing burden of generalized myasthenia gravis: a population-based retrospective cohort study in Taiwan. Front Neurol. 2023, 14:1203679. 10.3389\/fneur.2023.1203679","journal-title":"Front Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00297-0","article-title":"Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders","volume":"21","author":"Punga AR","year":"2022","unstructured":"Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022, 21:176-88. 10.1016\/S1474-4422(21)00297-0","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob D","year":"2008","unstructured":"Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008, 37:141-9. 10.1002\/mus.20950","journal-title":"Muscle Nerve"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3928\/00989134-20131108-01","article-title":"Myasthenia gravis","volume":"39","author":"Koch JA","year":"2013","unstructured":"Koch JA, Steele MR, Koch LM. Myasthenia gravis. J Gerontol Nurs. 2013, 39:11-5. 10.3928\/00989134-20131108-01","journal-title":"J Gerontol Nurs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2021.04.002","article-title":"Prevalence and associated factors of fatigue in autoimmune myasthenia gravis","volume":"31","author":"Ruiter AM","year":"2021","unstructured":"Ruiter AM, Verschuuren JJ, Tannemaat MR. Prevalence and associated factors of fatigue in autoimmune myasthenia gravis. Neuromuscul Disord. 2021, 31:612-21. 10.1016\/j.nmd.2021.04.002","journal-title":"Neuromuscul Disord"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13522","article-title":"Myasthenia gravis: the role of complement at the neuromuscular junction","volume":"1412","author":"Howard JF Jr","year":"2018","unstructured":"Howard JF Jr. Myasthenia gravis: the role of complement at the neuromuscular junction. Ann N Y Acad Sci. 2018, 1412:113-28. 10.1111\/nyas.13522","journal-title":"Ann N Y Acad Sci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.22608\/APO.2018301","article-title":"Treatment of ocular myasthenia gravis","volume":"7","author":"Cornblath WT","year":"2018","unstructured":"Cornblath WT. Treatment of ocular myasthenia gravis. Asia Pac J Ophthalmol (Phila). 2018, 7:257-9. 10.22608\/APO.2018301","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-98818-6.00010-8","article-title":"Myasthenia gravis and congenital myasthenic syndromes","volume":"195","author":"Gilhus NE","year":"2023","unstructured":"Gilhus NE. Myasthenia gravis and congenital myasthenic syndromes. Handb Clin Neurol. 2023, 195:635-52. 10.1016\/B978-0-323-98818-6.00010-8","journal-title":"Handb Clin Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-829589","article-title":"Seronegative myasthenia gravis","volume":"24","author":"Vincent A","year":"2004","unstructured":"Vincent A, McConville J, Farrugia ME, Newsom-Davis J. Seronegative myasthenia gravis. Semin Neurol. 2004, 24:125-33. 10.1055\/s-2004-829589","journal-title":"Semin Neurol"},{"key":"ref12","article-title":"Juvenile myasthenia gravis [Article in Spanish]","volume":"69","author":"Papazian O","year":"2009","unstructured":"Papazian O, Alfonso I. Juvenile myasthenia gravis [Article in Spanish]. Medicina (Buenos Aires). 2009, 69:71-83.","journal-title":"Medicina (Buenos Aires)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/088307389200700202","article-title":"Transient neonatal myasthenia gravis","volume":"7","author":"Papazian O","year":"1992","unstructured":"Papazian O. Transient neonatal myasthenia gravis. J Child Neurol. 1992, 7:135-41. 10.1177\/088307389200700202","journal-title":"J Child Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00776","article-title":"Autoimmune pathology in myasthenia gravis disease subtypes is governed by divergent mechanisms of immunopathology","volume":"11","author":"Fichtner ML","year":"2020","unstructured":"Fichtner ML, Jiang R, Bourke A, Nowak RJ, O'Connor KC. Autoimmune pathology in myasthenia gravis disease subtypes is governed by divergent mechanisms of immunopathology. Front Immunol. 2020, 11:776. 10.3389\/fimmu.2020.00776","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13546","article-title":"Roles of cytokines and T cells in the pathogenesis of myasthenia gravis","volume":"203","author":"Uzawa A","year":"2021","unstructured":"Uzawa A, Kuwabara S, Suzuki S, et al.. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clin Exp Immunol. 2021, 203:366-74. 10.1111\/cei.13546","journal-title":"Clin Exp Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2013.02.005","article-title":"The thymus in autoimmune myasthenia gravis: paradigm for a tertiary lymphoid organ","volume":"169","author":"Weiss JM","year":"2013","unstructured":"Weiss JM, Cufi P, Le Panse R, Berrih-Aknin S. The thymus in autoimmune myasthenia gravis: paradigm for a tertiary lymphoid organ. Rev Neurol (Paris). 2013, 169:640-9. 10.1016\/j.neurol.2013.02.005","journal-title":"Rev Neurol (Paris)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of myasthenia gravis - a comprehensive review","volume":"52","author":"Avidan N","year":"2014","unstructured":"Avidan N, Le Panse R, Berrih-Aknin S, Miller A. Genetic basis of myasthenia gravis - a comprehensive review. J Autoimmun. 2014, 52:146-53. 10.1016\/j.jaut.2013.12.001","journal-title":"J Autoimmun"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1558975","article-title":"Myasthenia gravis","volume":"35","author":"Gwathmey KG","year":"2015","unstructured":"Gwathmey KG, Burns TM. Myasthenia gravis. Semin Neurol. 2015, 35:327-39. 10.1055\/s-0035-1558975","journal-title":"Semin Neurol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.21037\/atm-19-363","article-title":"Serological diagnosis of myasthenia gravis and its clinical significance","volume":"11","author":"Li Y","year":"2023","unstructured":"Li Y, Peng Y, Yang H. Serological diagnosis of myasthenia gravis and its clinical significance. Ann Transl Med. 2023, 11:290. 10.21037\/atm-19-363","journal-title":"Ann Transl Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00212","article-title":"Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics","volume":"11","author":"Lazaridis K","year":"2020","unstructured":"Lazaridis K, Tzartos SJ. Autoantibody specificities in myasthenia gravis; implications for improved diagnostics and therapeutics. Front Immunol. 2020, 11:212. 10.3389\/fimmu.2020.00212","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.010","article-title":"Diagnosis of myasthenia gravis","volume":"36","author":"Pasnoor M","year":"2018","unstructured":"Pasnoor M, Dimachkie MM, Farmakidis C, Barohn RJ. Diagnosis of myasthenia gravis. Neurol Clin. 2018, 36:261-74. 10.1016\/j.ncl.2018.01.010","journal-title":"Neurol Clin"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-017-3194-0","article-title":"Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis","volume":"39","author":"Sciacca G","year":"2018","unstructured":"Sciacca G, Reggio E, Mostile G, Nicoletti A, Drago F, Salomone S, Zappia M. Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis. Neurol Sci. 2018, 39:341-5. 10.1007\/s10072-017-3194-0","journal-title":"Neurol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2017.08.030","article-title":"Effect of local cooling on excitation-contraction coupling in myasthenic muscle: another mechanism of ice-pack test in myasthenia gravis","volume":"128","author":"Yamamoto D","year":"2017","unstructured":"Yamamoto D, Imai T, Tsuda E, et al.. Effect of local cooling on excitation-contraction coupling in myasthenic muscle: another mechanism of ice-pack test in myasthenia gravis. Clin Neurophysiol. 2017, 128:2309-17. 10.1016\/j.clinph.2017.08.030","journal-title":"Clin Neurophysiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-282x2008000100025","article-title":"Ice pack test in the diagnosis of myasthenia gravis","volume":"66","author":"Almeida DF","year":"2008","unstructured":"Almeida DF, Radaeli Rde F, Melo AC Jr. Ice pack test in the diagnosis of myasthenia gravis. Arq Neuropsiquiatr. 2008, 66:96-8. 10.1590\/s0004-282x2008000100025","journal-title":"Arq Neuropsiquiatr"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2021.17.2.265","article-title":"Initial repetitive nerve stimulation test predicts conversion of ocular myasthenia gravis to generalized myasthenia gravis","volume":"17","author":"Kim KH","year":"2021","unstructured":"Kim KH, Kim SW, Shin HY. Initial repetitive nerve stimulation test predicts conversion of ocular myasthenia gravis to generalized myasthenia gravis. J Clin Neurol. 2021, 17:265-72. 10.3988\/jcn.2021.17.2.265","journal-title":"J Clin Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1177\/19418744231173829","article-title":"Utility of repetitive nerve stimulation in the diagnosis of myasthenia gravis in the inpatient setting","volume":"13","author":"Clifford KM","year":"2023","unstructured":"Clifford KM, Wu CK, Post D, Shaik R, Muppidi S. Utility of repetitive nerve stimulation in the diagnosis of myasthenia gravis in the inpatient setting. Neurohospitalist. 2023, 13:364-70. 10.1177\/19418744231173829","journal-title":"Neurohospitalist"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64032-1.00019-9","article-title":"Single fiber electromyography","volume":"160","author":"Juel VC","year":"2019","unstructured":"Juel VC. Single fiber electromyography. Handb Clin Neurol. 2019, 160:303-10. 10.1016\/B978-0-444-64032-1.00019-9","journal-title":"Handb Clin Neurol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-282x2007000300016","article-title":"Concentric needle single fiber electromyography: normative jitter values on voluntary activated extensor digitorum communis","volume":"65","author":"Kouyoumdjian JA","year":"2007","unstructured":"Kouyoumdjian JA, St\u00e5lberg EV. Concentric needle single fiber electromyography: normative jitter values on voluntary activated extensor digitorum communis. Arq Neuropsiquiatr. 2007, 65:446-9. 10.1590\/s0004-282x2007000300016","journal-title":"Arq Neuropsiquiatr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1590\/s0004-282x1996000400009","article-title":"Evaluation of the respiratory function in myasthenia gravis. An important tool for clinical feature and diagnosis of the disease","volume":"54","author":"Saraiva PA","year":"1996","unstructured":"Saraiva PA, de Assis JL, Marchiori PE. Evaluation of the respiratory function in myasthenia gravis. An important tool for clinical feature and diagnosis of the disease. Arq Neuropsiquiatr. 1996, 54:601-7. 10.1590\/s0004-282x1996000400009","journal-title":"Arq Neuropsiquiatr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2022.09.002","article-title":"The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study","volume":"32","author":"Remijn-Nelissen L","year":"2022","unstructured":"Remijn-Nelissen L, Verschuuren JJ, Tannemaat MR. The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study. Neuromuscul Disord. 2022, 32:790-9. 10.1016\/j.nmd.2022.09.002","journal-title":"Neuromuscul Disord"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10264-0","article-title":"Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review","volume":"268","author":"Lotan I","year":"2021","unstructured":"Lotan I, Hellmann MA, Wilf-Yarkoni A, Steiner I. Exacerbation of myasthenia gravis following corticosteroid treatment: what is the evidence? A systematic review. J Neurol. 2021, 268:4573-86. 10.1007\/s00415-020-10264-0","journal-title":"J Neurol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.116734","article-title":"Myasthenia gravis and azathioprine treatment: adverse events related to thiopurine S-methyl-transferase (TPMT) polymorphisms","volume":"412","author":"Lorenzoni PJ","year":"2020","unstructured":"Lorenzoni PJ, Kay CS, Zanlorenzi MF, Ducci RD, Werneck LC, Scola RH. Myasthenia gravis and azathioprine treatment: adverse events related to thiopurine S-methyl-transferase (TPMT) polymorphisms. J Neurol Sci. 2020, 412:116734. 10.1016\/j.jns.2020.116734","journal-title":"J Neurol Sci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410150615","article-title":"Azathioprine in the treatment of myasthenia gravis","volume":"15","author":"Witte AS","year":"1984","unstructured":"Witte AS, Cornblath DR, Parry GJ, Lisak RP, Schatz NJ. Azathioprine in the treatment of myasthenia gravis. Ann Neurol. 1984, 15:602-5. 10.1002\/ana.410150615","journal-title":"Ann Neurol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1159\/000050768","article-title":"Mycophenolate mofetil in the therapy of severe myasthenia gravis","volume":"46","author":"Schneider C","year":"2001","unstructured":"Schneider C, Gold R, Reiners K, Toyka KV. Mycophenolate mofetil in the therapy of severe myasthenia gravis. Eur Neurol. 2001, 46:79-82. 10.1159\/000050768","journal-title":"Eur Neurol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/s0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison AC","year":"2000","unstructured":"Allison AC, Eugui EM. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 2000, 47:85-118. 10.1016\/s0162-3109(00)00188-0","journal-title":"Immunopharmacology"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(85)90022-4","article-title":"Treatment of experimental myasthenia gravis with cyclosporin A","volume":"34","author":"Drachman DB","year":"1985","unstructured":"Drachman DB, Adams RN, McIntosh K, Pestronk A. Treatment of experimental myasthenia gravis with cyclosporin A. Clin Immunol Immunopathol. 1985, 34:174-88. 10.1016\/0090-1229(85)90022-4","journal-title":"Clin Immunol Immunopathol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-019-09622-4","article-title":"Intravenous cyclophosphamide monthly pulses in refractory myasthenia gravis","volume":"267","author":"Gomez-Figueroa E","year":"2020","unstructured":"Gomez-Figueroa E, Garcia-Trejo S, Bazan-Rodriguez L, Cervantes-Uribe R, Chac-Lezama G, L\u00f3pez-Hern\u00e1ndez JC, Vargas-Ca\u00f1as S. Intravenous cyclophosphamide monthly pulses in refractory myasthenia gravis. J Neurol. 2020, 267:674-8. 10.1007\/s00415-019-09622-4","journal-title":"J Neurol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1002\/mus.20411","article-title":"High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies","volume":"33","author":"Lin PT","year":"2006","unstructured":"Lin PT, Martin BA, Weinacker AB, So YT. High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies. Muscle Nerve. 2006, 33:433-5. 10.1002\/mus.20411","journal-title":"Muscle Nerve"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2012.06804.x","article-title":"Phase II trial of methotrexate in myasthenia gravis","volume":"1275","author":"Pasnoor M","year":"2012","unstructured":"Pasnoor M, He J, Herbelin L, Dimachkie M, Barohn RJ. Phase II trial of methotrexate in myasthenia gravis. Ann N Y Acad Sci. 2012, 1275:23-8. 10.1111\/j.1749-6632.2012.06804.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/s0955-3886(98)00022-8","article-title":"Plasmapheresis in myasthenia gravis. A survey","volume":"19","author":"Kuks JB","year":"1998","unstructured":"Kuks JB, Skallebaek D. Plasmapheresis in myasthenia gravis. A survey. Transfus Sci. 1998, 19:129-36. 10.1016\/s0955-3886(98)00022-8","journal-title":"Transfus Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.4103\/0972-5229.148631","article-title":"Therapeutic plasma exchange in the treatment of myasthenia gravis","volume":"19","author":"Kumar R","year":"2015","unstructured":"Kumar R, Birinder SP, Gupta S, Singh G, Kaur A. Therapeutic plasma exchange in the treatment of myasthenia gravis. Indian J Crit Care Med. 2015, 19:9-13. 10.4103\/0972-5229.148631","journal-title":"Indian J Crit Care Med"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7796833","article-title":"Effects of plasma exchange combined with immunoglobulin therapy on consciousness, immune function, and prognosis in patients with myasthenia gravis crisis: a prospective randomized test","volume":"2022","author":"Peng X","year":"2022","unstructured":"Peng X, Xie XB, Tan H, et al.. Effects of plasma exchange combined with immunoglobulin therapy on consciousness, immune function, and prognosis in patients with myasthenia gravis crisis: a prospective randomized test. Comput Math Methods Med. 2022, 2022:7796833. 10.1155\/2022\/7796833","journal-title":"Comput Math Methods Med"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159993","article-title":"Subcutaneous immunoglobulin therapy in the chronic management of myasthenia gravis: a retrospective cohort study","volume":"11","author":"Bourque PR","year":"2016","unstructured":"Bourque PR, Pringle CE, Cameron W, Cowan J, Chardon JW. Subcutaneous immunoglobulin therapy in the chronic management of myasthenia gravis: a retrospective cohort study. PLoS One. 2016, 11:e0159993. 10.1371\/journal.pone.0159993","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-020-00443-w","article-title":"Monoclonal antibody-based therapies for myasthenia gravis","volume":"34","author":"Alabbad S","year":"2020","unstructured":"Alabbad S, AlGaeed M, Sikorski P, Kaminski HJ. Monoclonal antibody-based therapies for myasthenia gravis. BioDrugs. 2020, 34:557-66. 10.1007\/s40259-020-00443-w","journal-title":"BioDrugs"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1080\/00015458.2016.1176419","article-title":"Video-assisted thoracoscopic surgery thymectomy versus open thymectomy in patients with myasthenia gravis: a meta-analysis","volume":"116","author":"Qi K","year":"2016","unstructured":"Qi K, Wang B, Wang B, Zhang LB, Chu XY. Video-assisted thoracoscopic surgery thymectomy versus open thymectomy in patients with myasthenia gravis: a meta-analysis. Acta Chir Belg. 2016, 116:282-8. 10.1080\/00015458.2016.1176419","journal-title":"Acta Chir Belg"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.5090\/jcs.21.059","article-title":"Robot-assisted thoracic surgery thymectomy","volume":"54","author":"Park S","year":"2021","unstructured":"Park S. Robot-assisted thoracic surgery thymectomy. J Chest Surg. 2021, 54:319-24. 10.5090\/jcs.21.059","journal-title":"J Chest Surg"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.thorsurg.2018.12.006","article-title":"Surgical techniques for myasthenia gravis: robotic-assisted thoracoscopic surgery","volume":"29","author":"Li F","year":"2019","unstructured":"Li F, Ismail M, Elsner A, Uluk D, Bauer G, Meisel A, Rueckert JC. Surgical techniques for myasthenia gravis: robotic-assisted thoracoscopic surgery. Thorac Surg Clin. 2019, 29:177-86. 10.1016\/j.thorsurg.2018.12.006","journal-title":"Thorac Surg Clin"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/01.pec.0000173353.76142.81","article-title":"Myasthenia gravis: myasthenia vs. cholinergic crisis","volume":"21","author":"Hetherington KA","year":"2005","unstructured":"Hetherington KA, Losek JD. Myasthenia gravis: myasthenia vs. cholinergic crisis. Pediatr Emerg Care. 2005, 21:546-51. 10.1097\/01.pec.0000173353.76142.81","journal-title":"Pediatr Emerg Care"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1055\/a-0599-0811","article-title":"Myasthenic crisis [Article in German]","volume":"86","author":"Stetefeld HR","year":"2018","unstructured":"Stetefeld HR, Schroeter M. Myasthenic crisis [Article in German] . Fortschr Neurol Psychiatr. 2018, 86:301-7. 10.1055\/a-0599-0811","journal-title":"Fortschr Neurol Psychiatr"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-829595","article-title":"Myasthenia gravis: management of myasthenic crisis and perioperative care","volume":"24","author":"Juel VC","year":"2004","unstructured":"Juel VC. Myasthenia gravis: management of myasthenic crisis and perioperative care. Semin Neurol. 2004, 24:75-81. 10.1055\/s-2004-829595","journal-title":"Semin Neurol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X20130108","article-title":"The myasthenic patient in crisis: an update of the management in neurointensive care unit","volume":"71","author":"Godoy DA","year":"2013","unstructured":"Godoy DA, Mello LJ, Masotti L, Di Napoli M. The myasthenic patient in crisis: an update of the management in neurointensive care unit. Arq Neuropsiquiatr. 2013, 71:627-39. 10.1590\/0004-282X20130108","journal-title":"Arq Neuropsiquiatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/198748-myasthenia-gravis-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:14Z","timestamp":1707509534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/198748-myasthenia-gravis-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.50017","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}